This table, produced by Public Health England to accompany 'Hepatitis C in England: 2017 report', collates the key statistics and information related to hepatitis C in England, including burden of infection; mortality and morbidity; incidence of infections; adequacy of harm reduction services; diagnosis rates, and the numbers of people accessing treatment.
Resources
Drug services professional
Around half of current injecting drug users will have hepatitis C, although this prevalence rate varies across the country. Find here tools, resources and other relevant documents to help drugs service staff raise awareness of hepatitis C amongst service users, and improve testing and access to care.
Showing 71 to 80 of 212 resources
-
Hepatitis C in England 2017: Headline table
England Mar 2017 Reports & Research PDF -
Hepatitis C in England 2017 report
This report by Public Health England has been produced to support monitoring of the recently agreed Global Health Sector Strategy on Viral Hepatitis goals, including the elimination of hepatitis C as a major public health threat by 2030. The report summarises the impact of action plans in England to drive down mortality from hepatitis C, reduce the number of new infections, and outlines the actions required to make further progress.England Mar 2017 Reports & Research, Strategy & Planning PDF -
Summary report: Midlands & East Hepatitis C Educational Event, Nottingham
This report provides a summary of the Midlands & East Hepatitis C Educational Event held by HCV Action and NHS England in Nottingham on Friday 10th February 2017.UK, East Midlands Reports & Research PDF -
Midlands & East Hepatitis C Educational Event in Nottingham: Presentations
On Friday 10th February 2017, HCV Action and NHS England held a Midlands & East Hepatitis C Educational Event in Nottingham. With hepatitis C Operational Delivery Networks (ODNs) still relatively new in operation, the event was held with the aim of offering the chance for ODNs across the Midlands and East region to come together to discuss their experiences, share best practice and develop solutions to some of the challenges they face as they seek to ensure the highest standards of hepatitis C care and treatment.UK, East Midlands Reports & Research MS Powerpoint -
Guidelines on hepatitis B and C testing
These are the first WHO guidelines on testing for chronic hepatitis B and C infection and complement published guidance by WHO on the prevention, care and treatment of chronic hepatitis C and hepatitis B infection. These guidelines outline the public health approach to strengthening and expanding current testing practices for hepatitis B and C, and are intended for use across age groups and populations.Rest of World Feb 2017 Other, Strategy & Planning PDF -
HCV Action and PHE hepatitis C roadshow in Manchester: Presentations
On 13th December 2016, HCV Action and Public Health England (PHE) staged a hepatitis C good practice roadshow in Manchester. The event was designed to showcase and share best practice in the prevention, diagnosis, testing and treatment of hepatitis C, and identify specific issues and potential solutions for tackling hepatitis C in Manchester and the wider north west region.UK, England, North West Other, Strategy & Planning PDF -
Hepatitis C Commissioning Toolkit
The Hepatitis C Commissioning Toolkit, originally published in September 2013 and most recently updated in September 2018, outlines the importance of effective commissioning in eliminating hepatitis C and sets out key commissioning responsibilities, with the intention of bringing clarity to an often highly fragmented commissioning landscape.England Case study, Tools & Templates, Strategy & Planning PDF -
Drug-related infectious diseases in Europe
This report provides an update on infectious diseases related to drug use in Europe for the period up to June 2016. It covers the most recent data both on infectious diseases among people who inject drugs in Europe, collected with the European Monitoring Centre for Drugs and Drug Addiction Drug-related infectious diseases (DRID) indicator, and on the responses in the area. It includes highlights and new findings discussed during the DRID indicator’s annual expert meeting, held in Lisbon on 6–8 June 2016.Rest of World Reports & Research PDF -
The lived experience of interferon-free treatments for hepatitis C: A thematic analysis
This research paper, published in the International Journal of Drug Policy, examines how interferon-free treatments for hepatitis C are being understood and experienced by patients.UK Reports & Research PDF -
Good practice case study: ROADS @ Bristol Drugs Project
This HCV Action good practice case study looks at the work done by ROADS (Recovery Orientated Alcohol & Drugs Service) @ Bristol Drugs Project. When ROADS took over the service in November 2013, under 12% of clients assessed as appropriate to be tested for hepatitis C went on to actually be tested. Bristol ROADS made a concerted effort to increase the number of people receiving hepatitis C tests by better coordinating services and finding ways to address the complications that prevented people who had agreed to be tested for hepatitis C from actually receiving the test.UK, South West Case study PDF